Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center

BACKGROUND: National organizations recommend screening for hepatitis B virus (HBV) before chemotherapy but differ regarding which patients should be screened. We aimed to determine contemporary screening rates at a cancer center and the possible influence on these rates of publication of national re...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Jessica P, Fisch, Michael J, Lok, Anna S-F, Zhang, Hong, Vierling, John M, Suarez-Almazor, Maria E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827843/
https://www.ncbi.nlm.nih.gov/pubmed/24209764
http://dx.doi.org/10.1186/1471-2407-13-534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827843/
https://www.ncbi.nlm.nih.gov/pubmed/24209764
http://dx.doi.org/10.1186/1471-2407-13-534

Ejemplares similares